Lipocine Stock Price History
LPCN Stock | USD 4.47 0.05 1.11% |
Below is the normalized historical share price chart for Lipocine extending back to June 15, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Lipocine stands at 4.47, as last reported on the 30th of January, with the highest price reaching 4.59 and the lowest price hitting 4.47 during the day.
If you're considering investing in Lipocine Stock, it is important to understand the factors that can impact its price. Lipocine has Sharpe Ratio of -0.0838, which conveys that the firm had a -0.0838 % return per unit of risk over the last 3 months. Lipocine exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Lipocine's Mean Deviation of 3.58, standard deviation of 4.77, and Risk Adjusted Performance of (0.02) to check out the risk estimate we provide.
At this time, Lipocine's Total Stockholder Equity is very stable compared to the past year. As of the 30th of January 2025, Common Stock Total Equity is likely to grow to about 10.7 K, while Other Stockholder Equity is likely to drop about 147.6 M. . At this time, Lipocine's Price Book Value Ratio is very stable compared to the past year. As of the 30th of January 2025, Price To Book Ratio is likely to grow to 0.68, though Price To Sales Ratio is likely to grow to (5.63). Lipocine Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 22nd of October 2013 | 200 Day MA 5.3927 | 50 Day MA 4.8282 | Beta 1.188 |
Lipocine |
Sharpe Ratio = -0.0838
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | LPCN |
Estimated Market Risk
4.75 actual daily | 42 58% of assets are more volatile |
Expected Return
-0.4 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Lipocine is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lipocine by adding Lipocine to a well-diversified portfolio.
Price Book 1.2784 | Enterprise Value Ebitda 0.651 | Price Sales 5.035 | Shares Float 5.2 M | Wall Street Target Price 10 |
Lipocine Stock Price History Chart
There are several ways to analyze Lipocine Stock price data. The simplest method is using a basic Lipocine candlestick price chart, which shows Lipocine price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | November 4, 2024 | 6.09 |
Lowest Price | December 2, 2024 | 4.3 |
Lipocine January 30, 2025 Stock Price Synopsis
Various analyses of Lipocine's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Lipocine Stock. It can be used to describe the percentage change in the price of Lipocine from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Lipocine Stock.Lipocine Price Daily Balance Of Power | (0.42) | |
Lipocine Price Action Indicator | (0.08) | |
Lipocine Accumulation Distribution | 431.37 | |
Lipocine Price Rate Of Daily Change | 0.99 |
Lipocine January 30, 2025 Stock Price Analysis
Lipocine Stock Price History Data
The price series of Lipocine for the period between Fri, Nov 1, 2024 and Thu, Jan 30, 2025 has a statistical range of 1.79 with a coefficient of variation of 8.79. The daily prices for the period are spread out with arithmetic mean of 5.0. The median price for the last 90 days is 4.91. The company underwent 1:17 stock split on 12th of May 2023.Open | High | Low | Close | Volume | ||
01/30/2025 | 4.52 | 4.59 | 4.47 | 4.47 | 16,500 | |
01/29/2025 | 4.57 | 4.64 | 4.42 | 4.52 | 79,470 | |
01/28/2025 | 4.55 | 4.77 | 4.41 | 4.57 | 95,745 | |
01/27/2025 | 4.85 | 5.10 | 4.52 | 4.52 | 27,664 | |
01/24/2025 | 4.64 | 4.83 | 4.50 | 4.69 | 12,569 | |
01/23/2025 | 4.40 | 4.70 | 4.40 | 4.54 | 39,410 | |
01/22/2025 | 4.66 | 4.70 | 4.38 | 4.39 | 30,376 | |
01/21/2025 | 4.38 | 4.73 | 4.32 | 4.60 | 19,789 | |
01/17/2025 | 4.47 | 4.56 | 4.25 | 4.37 | 42,027 | |
01/16/2025 | 4.84 | 4.84 | 4.42 | 4.45 | 13,460 | |
01/15/2025 | 4.71 | 4.89 | 4.62 | 4.62 | 31,200 | |
01/14/2025 | 4.48 | 4.73 | 4.48 | 4.60 | 14,409 | |
01/13/2025 | 4.86 | 4.86 | 4.50 | 4.59 | 48,867 | |
01/10/2025 | 5.24 | 5.24 | 4.82 | 4.89 | 30,976 | |
01/08/2025 | 5.30 | 5.40 | 4.96 | 5.23 | 24,592 | |
01/07/2025 | 5.03 | 5.50 | 5.03 | 5.29 | 56,010 | |
01/06/2025 | 5.20 | 5.20 | 5.00 | 5.00 | 9,784 | |
01/03/2025 | 4.89 | 5.10 | 4.82 | 5.06 | 24,777 | |
01/02/2025 | 4.86 | 5.02 | 4.76 | 4.86 | 30,166 | |
12/31/2024 | 4.56 | 5.06 | 4.56 | 4.88 | 41,591 | |
12/30/2024 | 4.70 | 4.79 | 4.50 | 4.58 | 31,845 | |
12/27/2024 | 4.52 | 4.91 | 4.52 | 4.76 | 33,292 | |
12/26/2024 | 4.81 | 5.22 | 4.60 | 4.72 | 46,840 | |
12/24/2024 | 4.82 | 4.93 | 4.81 | 4.90 | 6,978 | |
12/23/2024 | 4.82 | 4.92 | 4.57 | 4.80 | 65,186 | |
12/20/2024 | 4.70 | 5.00 | 4.70 | 4.87 | 64,308 | |
12/19/2024 | 4.80 | 5.06 | 4.68 | 4.68 | 13,335 | |
12/18/2024 | 5.19 | 5.25 | 4.74 | 4.74 | 47,748 | |
12/17/2024 | 4.70 | 5.28 | 4.70 | 5.21 | 80,811 | |
12/16/2024 | 4.95 | 5.14 | 4.90 | 4.99 | 17,918 | |
12/13/2024 | 5.38 | 5.38 | 5.00 | 5.02 | 14,130 | |
12/12/2024 | 5.29 | 5.47 | 5.15 | 5.26 | 11,962 | |
12/11/2024 | 5.33 | 5.40 | 5.00 | 5.31 | 32,611 | |
12/10/2024 | 5.09 | 5.32 | 5.00 | 5.20 | 26,252 | |
12/09/2024 | 5.08 | 5.43 | 5.01 | 5.15 | 28,616 | |
12/06/2024 | 5.00 | 5.16 | 4.82 | 5.10 | 34,443 | |
12/05/2024 | 4.93 | 5.00 | 4.86 | 4.99 | 16,024 | |
12/04/2024 | 4.71 | 4.95 | 4.66 | 4.91 | 16,147 | |
12/03/2024 | 4.39 | 4.82 | 4.39 | 4.73 | 36,917 | |
12/02/2024 | 4.49 | 4.50 | 4.19 | 4.30 | 15,982 | |
11/29/2024 | 4.48 | 4.59 | 4.31 | 4.54 | 14,628 | |
11/27/2024 | 4.46 | 4.78 | 4.45 | 4.45 | 42,840 | |
11/26/2024 | 5.03 | 5.03 | 4.01 | 4.42 | 123,311 | |
11/25/2024 | 5.15 | 5.20 | 4.89 | 5.01 | 19,373 | |
11/22/2024 | 5.01 | 5.20 | 4.87 | 5.15 | 10,670 | |
11/21/2024 | 4.71 | 5.15 | 4.71 | 5.00 | 13,635 | |
11/20/2024 | 4.73 | 4.98 | 4.64 | 4.71 | 5,283 | |
11/19/2024 | 4.70 | 4.94 | 4.67 | 4.76 | 13,500 | |
11/18/2024 | 4.92 | 4.97 | 4.63 | 4.72 | 21,729 | |
11/15/2024 | 5.00 | 5.23 | 4.87 | 4.89 | 11,401 | |
11/14/2024 | 5.10 | 5.23 | 5.04 | 5.21 | 7,503 | |
11/13/2024 | 5.07 | 5.40 | 4.99 | 5.18 | 14,732 | |
11/12/2024 | 5.25 | 5.33 | 4.79 | 5.10 | 18,076 | |
11/11/2024 | 4.85 | 5.53 | 4.83 | 5.33 | 37,056 | |
11/08/2024 | 5.52 | 5.93 | 4.70 | 4.76 | 66,654 | |
11/07/2024 | 6.00 | 6.16 | 5.25 | 5.59 | 64,658 | |
11/06/2024 | 5.90 | 6.06 | 5.64 | 6.06 | 29,280 | |
11/05/2024 | 6.08 | 6.08 | 5.36 | 5.83 | 38,419 | |
11/04/2024 | 6.16 | 6.17 | 5.54 | 6.09 | 34,158 | |
11/01/2024 | 5.80 | 6.13 | 5.54 | 6.08 | 71,205 | |
10/31/2024 | 5.45 | 5.68 | 5.39 | 5.54 | 19,168 |
About Lipocine Stock history
Lipocine investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Lipocine is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Lipocine will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Lipocine stock prices may prove useful in developing a viable investing in Lipocine
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 6.1 M | 6.4 M | |
Net Loss | -12.4 M | -13 M |
Lipocine Quarterly Net Working Capital |
|
Lipocine Stock Technical Analysis
Lipocine technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
All Next | Launch Module |
Lipocine Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Lipocine's price direction in advance. Along with the technical and fundamental analysis of Lipocine Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Lipocine to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.02) | |||
Jensen Alpha | (0.14) | |||
Total Risk Alpha | (0.61) | |||
Treynor Ratio | 0.3185 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lipocine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.75) | Revenue Per Share | Quarterly Revenue Growth 137.519 | Return On Assets | Return On Equity |
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipocine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.